Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Sell

C

Mirati Therapeutics, Inc. Common Stock (MRTX)

Pharmaceutical Preparations

https://www.mirati.com

Mirati Therapeutics Inc is a clinical-stage oncology company developing novel therapeutics to address the genetic and immunological promoters of cancer. It operates in a single geographical segment being the United States.

3545 CRAY COURT
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/15/2013

Market Cap

4,117,669,755

Shares Outstanding

70,150,000

Weighted SO

70,147,706

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

RETA --.--%

SRPT --.--%

KRYS --.--%

ICPT --.--%

DAWN --.--%

AMLX --.--%

TERN --.--%

APLS --.--%

Beta

0.7700

Last Div

0.0000

Range

27.3-64.41

Chg

-0.1000

Avg Vol

1778618

Mkt Cap

4117669755

Exch

NASDAQ

Country

US

Phone

858 332 3410

DCF Diff

62.8259

DCF

-4.1259

Div Yield

0.0000

P/S

107.8178

EV Multiple

-5.1183

P/FV

4.0309

Div Yield %

0.0000

P/E

-5.3236

PEG

0.3029

Payout

0.0000

Current Ratio

7.5418

Quick Ratio

7.2541

Cash Ratio

1.8832

DSO

192.3774

DIO

1782.2045

Op Cycle

1974.5818

DPO

3356.5322

CCC

-1381.9504

Gross Margin

0.8919

Op Margin

-20.0275

Pretax Margin

-18.9999

Net Margin

-18.7647

Eff Tax Rate

0.0139

ROA

-0.6344

ROE

-0.8110

ROCE

-0.7708

NI/EBT

0.9876

EBT/EBIT

0.9487

EBIT/Rev

-20.0275

Debt Ratio

0.0445

D/E

0.0531

LT Debt/Cap

0.0427

Total Debt/Cap

0.0504

Int Coverage

82.4213

CF/Debt

-11.8291

Equity Multi

1.1936

Rec Turnover

1.8973

Pay Turnover

0.1087

Inv Turnover

0.2048

FA Turnover

0.7472

Asset Turnover

0.0338

OCF/Share

-9.1409

FCF/Share

-9.1692

Cash/Share

15.0237

OCF/Sales

-15.5559

FCF/OCF

1.0031

CF Coverage

-11.8291

ST Coverage

-74.0767

CapEx Coverage

-323.4050

Div&CapEx Cov

-323.4050

P/BV

4.0309

P/B

4.0309

P/S

107.8178

P/E

-5.3236

P/FCF

-6.9096

P/OCF

-6.4217

P/CF

-6.4217

PEG

0.3029

P/S

107.8178

EV Multiple

-5.1183

P/FV

4.0309

DPS

0.0000

Latest Headlines (EST)

Zacks Investment Research Jan 03, 14:05 Bristol Myers (BMY) NSCLC Drug Application Gets EMA Validation Seeking Alpha Dec 31, 02:49 Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Seeking Alpha Dec 31, 02:49 Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Seeking Alpha Dec 31, 02:49 Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Seeking Alpha Dec 31, 02:49 Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Benzinga Dec 20, 07:00 Analyst Expectations For Mirati Therapeutics's Future Seeking Alpha Nov 12, 01:40 Verastem: Potential Accelerated Approval Filing In H1 2024 Seeking Alpha Nov 12, 01:40 Verastem: Potential Accelerated Approval Filing In H1 2024 Seeking Alpha Nov 12, 01:40 Verastem: Potential Accelerated Approval Filing In H1 2024 The Motley Fool Nov 08, 05:21 3 No-Brainer Stocks to Buy With $500 Right Now Benzinga Nov 07, 07:50 Appian To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Tuesday

Revenue Product Segmentation